PoribioR&D
Regenerative Medicine Research Center
Since its establishment in 2022, the center has focused on developing optimal processes for the mass production of PDRN/PN. We aim to enhance the quality of raw materials and optimize production efficiency to strengthen our competitiveness. Furthermore, we are conducting research to develop products and verify the safety and efficacy of PDRN/PN raw materials in collaboration with domestic and international specialized institutions.
Through this center, PORIBIO aims to establish itself as a global leader in the PDRN/PN market.
Research Strategy
Customer-centered R&D of Regenerative Medicine
As a global leader in the PDRN/PN sector, PORIBIO conducts research and development for regenerative medicine with the customer at the forefront.
We consistently strive to create unique products by prioritizing the needs of our customers to enhance their quality of life.
Furthermore, we focus on developing regenerative treatments suitable for the aging population to proactively address upcoming changes in the healthcare sector.
Key R&D Strategies of PORIBIO
- Enhancement of core technologies
- Advancement of existing technologies
- Expansion of related technologies
- Development of essential technologies for regenerative treatments
- Diversification
- Establishment and management of related domestic and international collaborative businesses through open innovation
Through customer-focused regenerative medicine research and development,
we will build global-level research capabilities and create unique value.